Team leader

Objectives of the team

To achieve practical vaccine implementation, we conduct research and development for vaccine and new modality projects, as well as development up to the stage of licensing to companies.

Description of research and development by the team

• Development research of novel LNP formulations for vaccine applications of Tfh cell epitopes.
• Development research of　ｍRNA-LNP vaccine for Lassa Virus
• Development of novel LNP modalities with enhanced thermal stability
• Development research of　ｍRNA-LNP vaccine for SFTS Virus
• Research on platforms that contribute to the practical implementation of vaccines